Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study

Archives of General Psychiatry

Volumn 49, Issue 11, 1992, Pages 881-887

  O'malley, Stephanie S ^a,b   Jaffe, Adam J ^a,b   Chang, Grace ^c   Schottenfeld, Richard S ^a   Meyer, Roger E ^b,d   Rounsaville, Bruce ^a,b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; PLACEBO; RIBOFLAVIN;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE SEVERITY; DRINKING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RELAPSE; VERTIGO; WEIGHT REDUCTION;

ADAPTATION, PSYCHOLOGICAL; ADULT; ALCOHOL DRINKING; ALCOHOLISM; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; NALTREXONE; NONDIRECTIVE THERAPY; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUPPORT, U.S. GOV'T, P.H.S.; TEMPERANCE;

EID: 0026498986     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1992.01820110045007     Document Type: Article

References (24)

1. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke J, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949-958.
2. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry. 1989;50:403-412.
3. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick DC, lber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neidershiser D, Nocks JJ, Shaw S. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA. 1986;256:1449-1455.
4. Reid L, Delconte J, Nichols M, Bilsky E, Hubbell C. Tests of opioid deficiency hypotheses of alcoholism. Alcohol. 1991;8:247-257.
5. Volpicelli JR, Davis MA, Olgin JE. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci. 1986:841-847.
6. Reid LD, Hunter GA. Morphine and naloxone modulate intake of ethanol. Alcohol. 1984;38:33-37.
7. Froehlich JC, Harts J, Lumeng L. Excerpt Med Int Cong Ser. 1988;805:235-238.
8. Berg BJ, Volpicelli JR, Alterman Al, O'Brien CP. The relationship between endogenous opioids and alcohol drinking: the opioid compensation hypothesis. Presented at the International Society for Biomedical Research on Alcoholism; 1990 Satellite Symposium on Novel Pharmacological Interventions for Alcoholism; June 16, 1990; Toronto, Ontario.
9. Volpicelli JR, O'Brien CP, Alterman Al, Hayshida M. Naltrexone and the treatment of alcohol dependence: initial observations. In: Reid LB, ed. Opioids, Bulimia, Alcohol Abuse and Alcoholism. New York, NY: SpringerVerlag NY Inc; 1990:195-214.
10. Marlatt GA, Gordon JR, eds. Relapse Prevention. New York, NY: Guilford Press; 1985.
11. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1987.
12. Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-III-R, Patient Version. New York, NY: Biometric Research Department, New York State Psychiatric Institute; 1985.
13. Morgan CJ, Kosten TR. Potential toxicities of high doses of naltrexone in patients with appetitive disorders. In: Reid LD, ed. Opioids, Bulimia, and Alcohol Abuse and Alcoholism. New York, NY: Springer-Verlag NY Inc; 1990:261-280.
14. Fuller RK, Williford WO, Lee KK, Derman R. Veterans Administration cooperative study of disulfiram in the treatment of alcoholism: study design and methodological considerations. Controlled Clin Trials. 1984;5:263-273.
15. Jaffe AJ, Korner P, Witte G, Brown J. Relapse Prevention for the Treatment of Problem Drinking: A Manual for Therapists and Patients. New Haven, Conn: Yale University School of Medicine; Farmington, Conn: University of Connecticut Health Center; 1989.
16. Carroll K, Schottenfield R. A Therapist's Manual for Relapse Prevention in the Treatment of Alcoholism. New Haven, Conn: Yale University School of Medicine; 1988.
17. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper T, Sanders B. Developing a prototype for evaluating alcohol treatment effectiveness. In: Sobell LC, Sobell MB, Ward E, eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York, NY: Pergamon Press; 1980:129-150.
18. Helzer JE, Robins LN, Croughan JL, Welner A. Renard diagnostic interview. Arch Gen Psychiatry. 1981;38:393-398.
19. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
20. Elkin I, Shea T, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry. 1989;46:971-982.
21. Babor TF, Korner P, Wilber C, Good SP. Screening and early intervention strategies for harmful drinkers: initial lessons from the Amethyst project. Aust Drug Alcohol Rev. 1987;6:325-339.
22. Supnick JA, Colletti G. Relapse coping and problem solving training following treatment for smoking. Addict Behav. 1984;9:401-404.
23. Cooney NL, Kopel SA, McKeon P. Controlled relapse training and self-efficacy in ex-smokers. Read before the 19th Annual Meeting of the American Psychological Association; August 1982; Washington, DC.
24. Hall S, Havassy BE, Wasserman DA. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol. 1990;58:175-181.